Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
BMC Pulmonary Medicine
|
June 3, 2014
Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment
Julia Hentschel, Manuela Jäger, Natalie Beiersdorf, et al.
Clinical Chemistry and Laboratory Medicine
|
April 7, 2021
Audit of sweat chloride testing reveals analytical errors
Freerk Prenzel, Uta Ceglarek, Ines Adams, et al.
NIHR Open Research
|
August 14, 2024
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study
Christabella Ng, Neele S Dellschaft, Caroline Hoad, et al.
Frontiers in Pharmacology
|
May 19, 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
Jochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 23, 2025
Validation of the CFAbd-Score.kid©, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosis
Pauline Sadrieh, Lilith Bechinger, Franziska Duckstein, et al.
Frontiers in Pharmacology
|
June 20, 2022
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
Jochen G Mainz, Carlos Zagoya, Louise Polte, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 18, 2013
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation
Jane C Davies, Claire E Wainwright, Gerard J Canny, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 9, 2016
Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial
Jochen G Mainz, Ulrike Schumacher, Katja Schädlich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 21, 2020
Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging
Christabella Ng, Neele S Dellschaft, Caroline L Hoad, et al.
Microbiology Spectrum
|
March 9, 2023
The Cystic Fibrosis Upper and Lower Airway Metagenome
Katarzyna Pienkowska, Marie-Madlen Pust, Margaux Gessner, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
BMC Pulmonary Medicine
|
June 3, 2014
Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment
Julia Hentschel, Manuela Jäger, Natalie Beiersdorf, et al.
Clinical Chemistry and Laboratory Medicine
|
April 7, 2021
Audit of sweat chloride testing reveals analytical errors
Freerk Prenzel, Uta Ceglarek, Ines Adams, et al.
NIHR Open Research
|
August 14, 2024
A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study
Christabella Ng, Neele S Dellschaft, Caroline Hoad, et al.
Frontiers in Pharmacology
|
May 19, 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
Jochen G Mainz, Carlos Zagoya, Louise Polte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
July 23, 2025
Validation of the CFAbd-Score.kid©, a Novel gastrointestinal patient reported outcome measure, specific for children with cystic fibrosis
Pauline Sadrieh, Lilith Bechinger, Franziska Duckstein, et al.
Frontiers in Pharmacology
|
June 20, 2022
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
Jochen G Mainz, Carlos Zagoya, Louise Polte, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 18, 2013
Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation
Jane C Davies, Claire E Wainwright, Gerard J Canny, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 9, 2016
Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial
Jochen G Mainz, Ulrike Schumacher, Katja Schädlich, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 21, 2020
Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging
Christabella Ng, Neele S Dellschaft, Caroline L Hoad, et al.
Microbiology Spectrum
|
March 9, 2023
The Cystic Fibrosis Upper and Lower Airway Metagenome
Katarzyna Pienkowska, Marie-Madlen Pust, Margaux Gessner, et al.
Page
of 8